A shrinkage-based CV-TMLE global test learns optimal weights for composite endpoints to boost power in rare disease studies with heterogeneous effects across multiple outcomes.
Title resolution pending
1 Pith paper cite this work. Polarity classification is still indexing.
1
Pith paper citing it
fields
stat.ME 1years
2026 1verdicts
UNVERDICTED 1representative citing papers
citing papers explorer
-
A CV-TMLE global test approach to improve power in rare disease clinical studies with multiple-component endpoints
A shrinkage-based CV-TMLE global test learns optimal weights for composite endpoints to boost power in rare disease studies with heterogeneous effects across multiple outcomes.